Supraventricular tachycardia in neonates: Antiarrhythmic drug choice dilemma

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue SUPPL. 3, 2010, Pages 30-33

  Tavera, Maria Cristina ^a   Bassareo, Pier Paolo ^a   Neroni, Paola ^a   Follese, Chiara ^a   Manca, Donatella ^a   Montis, Sabrina ^a   Tumbarello, Roberto ^a  

^a BROTZU HOSPITAL   (Italy)

Author keywords

antiarrhythmic drug; neonates; prophylaxis; Tachycardia; treatment

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FLECAINIDE; NADOLOL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL;

ANTIARRHYTHMIC ACTIVITY; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MONITORING; DRUG SAFETY; HEART ATRIOVENTRICULAR NODE; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HUMAN; INFANT; LOADING DRUG DOSE; LONG TERM CARE; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; SHORT COURSE THERAPY; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT; WOLFF PARKINSON WHITE SYNDROME; CHEMOPROPHYLAXIS; DECISION MAKING; METHODOLOGY; NEWBORN; NEWBORN DISEASE; PHYSIOLOGY;

ANTI-ARRHYTHMIA AGENTS; CHEMOPREVENTION; CHOICE BEHAVIOR; DECISION MAKING; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; RECURRENCE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 77957948969     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.517937     Document Type: Review

References (20)

1. Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981;98:875-882.
2. Deal BJ. Supraventricular tachycardia mechanisms and natural history. In: Deal BJ, Wolff G, Gelband H, editors. Current concepts in diagnosis and management of arrhythmias in infants and children. Armonk, NY: Futura Publishing; 1998. pp. 117-143.
3. Von Bernuth G, Engelhardt W, Kramer HH, Singer H, Schneider P, Ulmer H, Brodherr-Heberlein S, Kienast W, Lang D, Lindinger A, et al. Atrial automatic tachycardia in infancy and childhood. Eur Heart J 1992;13:1410-1415.
4. Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen EH, editors. Symposium on cardiac arrhythmias. Denmark: ASTRA; 1970. pp. 449-501.
5. Radford D. Side effects of verapamil in infants. Arch Dis Child 1983;58:465-466.
6. Till JA, Shinebourne EA, Rowland E, Ward DE, Bhamra R, Haga P, Johnston A, Holt DW. Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J 1989;62:133-139.
7. Ackland F, Singh R, Thayyil S. Flecainide induced ventricular fibrillation in a neonate. Heart 2003;89:1261.
8. Pfammatter JP, Stocker FP. Re-entrant supraventricular tachycardia in infancy: current role of prophylactic digoxin treatment. Eur J Pediatr 1998;157:101-106.
9. Perry JC. Pharmacologic therapy of arrhythmias. In: Deal BJ, Wolff G, Gelband H, editors. Current concepts in diagnosis and management of arrhythmias in infants and children. Armonk, NY: Futura Publishing; 1998. pp. 267-305.
10. Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996;131:66-72.
11. Trippel DL, Gillette PC. Atenolol in children with supraventricular tachycardia. Am J Cardiol 1989;64:233-236.
12. O Sullivan JJ, Gardiner HM, Wren C. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants? J Am Coll Cardiol 1995;26:991-994.
13. Fish FA, Gillette PC, Benson DW, Jr. Proarrhythmia, cardiac arrest and sudden death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 1991;18:356-365.
14. Reimer A, Paul T, Kallfelz HC. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dyshythmias. Am J Cardiol 1991;68:741-744.
15. Janousek J, Paul T, Reimer A, Kallfelz HC. Usefulness of propafenone for supraventricular arrhythmias in infants and children. Am J Cardiol 1993;72:294-300.
16. Pfammatter JP, Paul T. New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol 1997;18:28-34.
17. Pfammatter JP, Paul T, Lehmann C, Kallfelz HC. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 1995;26:1002-1007.
18. Kugler JD, Danford DA. Management of infants, children and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996;129:324-338.
19. Guccione P, Paul T, Garson A Jr.. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 1990;15:1118-1124.
20. Paul T, Guccione P. New antiarrhythmic drugs in pediatric use: amiodarone. Pediatr Cardiol 1994;15:132-138.